Reports

Ideas That Generate Results

Genetic Testing Market Outlook to 2017

Genetic Testing Market Outlook to 2017

Format :  Adobe Reader (PDF) Upto 24 hour delivery
Publish Date : May, 2013| No. of Pages : 140

Share |
 
Please make your selection :
Electronic Access - Single User License
US$ 1200.00  720.00
CD-ROM Mail Delivery
US$ 1300.00  780.00
Hard Copy Mail Delivery
US$ 1300.00  780.00
Electronic Access - Multi-User License
US$ 1700.00  1020.00

1. Analyst View

2. Research Methodology

3. Introduction to Genetic Testing

4. Global Genetic Testing Market Overview
     4.1 Market Outlook
     4.2 Genetic Testing Laboratories - Unmet Need Analysis
     4.3 DTC Genetic Testing

5. Disease-Wise Analysis
     5.1 Alzheimer's Disease
     5.2 Cystic Fibrosis
     5.3 Cancer

6. Country-Level Analysis
     6.1 US
            6.1.1 Market Overview
            6.1.2 Recent Developments
     6.2 Europe
            6.2.1 Market Overview
            6.2.2 Recent Developments
     6.3 Asia
            6.3.1 Market Overview
            6.3.2 Recent Developments

7. Emerging Sectors
     7.1 Next-Generation Sequencing
     7.2 Non-Invasive Prenatal diagnostics (NIPD)
     7.3 Whole Genome Sequencing (WGS) for Cancer
     7.4 Personalized medicine

8. Competitive Assessment
     8.1 Abbott Laboratories
            8.1.1 Company Overview
            8.1.2 Product Offering
            8.1.3 Key Financials
            8.1.4 Recent Developments
            8.1.5 Strengths & Weaknesses
     8.2 Roche Diagnostics
            8.2.1 Company Overview
            8.2.2 Product Offering
            8.2.3 Key Financials
            8.2.4 Recent Developments
            8.2.5 Strengths & Weaknesses
     8.3 Myriad Genetics
             8.3.1 Company Overview
             8.3.2 Product Offering
             8.3.3 Key Financials
             8.3.4 Recent Developments
             8.3.5 Strengths & Weaknesses
     8.4 Life Technologies Corporation
            8.4.1 Company Overview
            8.4.2 Product Offering
            8.4.3 Key Financials
            8.4.4 Recent Developments
            8.4.5 Strengths & Weaknesses
     8.5 Genomic Health
            8.5.1 Company Overview
            8.5.2 Product Offering
            8.5.3 Key Financials
            8.5.4 Recent Developments
            8.5.5 Strengths & Weaknesses
     8.6 Sequenom
            8.6.1 Company Overview
            8.6.2 Product Offering
            8.6.3 Key Financials
            8.6.4 Recent Developments
            8.6.5 Strengths & Weaknesses
     8.7 Transgenomic
            8.7.1 Company Overview
            8.7.2 Product Offering
            8.7.3 Key Financials
            8.7.4 Recent Developments
            8.7.5 Strengths & Weaknesses
     8.8 Dako (Agilent Technologies)
            8.8.1 Company Overview
            8.8.2 Product Offering
            8.8.3 Key Financials
            8.8.4 Recent Development
            8.8.5 Strengths & Weaknesses
     8.9 Gen-Probe (Hologic)
            8.9.1 Company Overview
            8.9.2 Product Offering
            8.9.3 Key Financials
            8.9.4 Key Activities
            8.9.5 Strengths & Weaknesses
     8.10 Quest Diagnostics
            8.10.1 Company Overview
            8.10.2 Products Offerings
            8.10.3 Key Financials
            8.10.4 Recent Developments
            8.10.5 Strengths and Weaknesses
     8.11 Genoptix (Novartis)
            8.11.1 Company Overview
            8.11.2 Product Offerings
            8.11.3 Key Financials
            8.11.4 Recent Developments
            8.11.5 Strengths and Weaknesses
     8.12 Clarient (GE Healthcare)
            8.12.1 Company Overview
            8.12.2 Product Offerings
            8.12.3 Key Financials
            8.12.4 Recent Developments
            8.12.5 Strengths and Weaknesses

Not able to find data you are looking for? Ask our Research Analyst.

media citation

get in touch

Please fill-in the information below.